Incyte Corporation

US$119.65As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:INCYHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 3.23%
Div yield —
ROE 7.84%
Biotechnology
Beta (5Y) 0.78
PE TTM 61.55
TSR TTM 28.00%
Mkt cap US$24.39B
ROIC 53.44%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$118
(1.29%)
(74.28%)
Hold 4|10|12|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.38
1.32
1.46
1.56
21.57%
8.23%
11.65%
15.27%
Revenue$B
1.520
1.547
1.604
1.617
4.36%
7.80%
11.55%
8.62%
Peers (US$24.39B)
Cap (US$)
PE
16.98B
20.78x
Capital
TTM
5Y
10Y
Leveragex
3.802
0.306
0.328
EBIT/Intx
1.822
0.117
0.119
Own earn%
26.67
(19.04)
(1.91)
Sh yield%
11.50
38.85
39.37
Owners
Insiders/Inst%
3.20
24.33
Short interest%
4.07
SBC / revenue%
2.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
11–18
$1 testx
−0.1
Incr. ROIC%
5